During the past decade, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello conducted 74 clinical trials. In the 10-year time frame, 74 clinical trials started and 30 clinical trials were completed, i.e. on average, 40.5% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 25 clinical trials were completed. i.e. 96.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 18 trials, followed by "Celgene" with 13 trials sponsored, "Incyte Corporation" with 10 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored and "Fondazione Italiana Linfomi ONLUS" with 7 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello" #1 collaborator was "European Commission" with 2 trials as a collaborator, "ANìMO (National Association of Hospital Medicine Nurses)" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator and "Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT)" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello" are "Crohn Disease" (8 trials), "Leukemia" (5 trials), "Multiple Myeloma" (5 trials), "Acute Lymphoblastic Leukemia" (4 trials) and "Acute Promyelocytic Leukemia" (4 trials). Many other conditions were trialed in "Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello" are "Drug" (76 trials), "Other" (18 trials), "Biological" (5 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Imatinib" (4 trials), "Parsaclisib" (4 trials), "Rituximab" (4 trials) and "Dexamethasone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello" are 101 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello". undefined are not yet recruiting, 22 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, 2 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello has several departments that took part in Clinical trials: "Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo" - 26 trials, "Internal Medicine Division of the "Cervello-Villa Sofia" Hospital" - 9 trials, "Istituto Di Clinica Medica 1 A; Divisione Di Medicina Generale E Gastroenterologia" - 3 trials, "Aor Villa Sofia-Cervello P.O. Cervello - U.O. Cardiologia - Cervello" - 3 trials, "Aor Villa Sofia-Cervello Po Villa Sofia - U.O.C. Cardiologia E Utic - Villa Sofia" - 2 trials, "AO Ospedali Riuniti Villa Sofia-Cervello;PO Villa Sofia - UO Neurologia - U.O.S. Neuroimmunologia" - 3 trials